RxDoctor Payments Data

Niccole Ranz

Family Medicine · Rockford, ILNPI 1194897223

Payments from drug & device makers

$1,311in general payments, 2019–2025

Across 50 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$383
  • Novo Nordisk$185
  • AbbVie$142
  • Otsuka America Pharmaceutical, Inc.$113
  • Acadia Pharmaceuticals Inc$87
  • GSK$53
  • plus $349 from 13 others

What the payments were for

  • Food & beverage$1,311100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,311 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$13,820
Medicare patients
68
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$64,197
EliquisApixaban14$19,421
OzempicSemaglutide14$16,980
TrulicityDulaglutide12$13,433
Levothyroxine Sodium138$1,156
Liothyronine Sodium23$886
Rosuvastatin Calcium73$728
Amlodipine Besylate65$594
Atorvastatin Calcium58$548
Metoprolol Succinate27$466
Tamsulosin Hcl21$434
Olmesartan Medoxomil29$430
Ezetimibe25$415
Irbesartan19$391
Escitalopram Oxalate16$379

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$383$77,63046 claims
PfizerEliquis$21$19,42114 claims
Novo NordiskOzempic$185$16,98014 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$1,156138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →